3 ms·
The Heroes of CRISPR
- peter303 11y agoI guess with all these contributions, where do you draw the line for the inevitable Nobel Prize? When these structures were first discovered? Or when some could use them for genevediting?
- skosuri 11y agoPossibly both. Either way, tons of people always get left out.
- Moshe_Silnorin 11y agoThe patent thicket surrounding it is looking quite daunting, which I find mildly enraging. However, I have mixed feeling on biotechnology. Weaponized biotechnology looks to be getting disturbingly cheap; maybe these absurd government-granted monopolies will do some good in slowing this down.
- api 11y agoTerrorists aren't going to balk at patent infringement.
- onetimePete 11y agoWe weakend encryption to get to the terrorists- and now they got there own.
- mortenjorck 11y agoFinally, the narrative underscores that scientific breakthroughs are rarely eureka moments. They are typically ensemble acts, played out over a decade or more, in which the cast becomes part of something greater than what any one of them could do alone. An excellent closing paragraph. Even if the majority of the technical concepts in this paper were beyond my grasp, I did take this much away from it.
- a_bonobo 11y agoComments on PubPeer are very negative about the undisclosed conflict of interest of OP's author: https://pubpeer.com/publications/D400145518C0A557E9A79F7BB20294#fb44022 https://pubpeer.com/publications/D400145518C0A557E9A79F7BB20...
- geyang 11y agoThanks for this reference!
- deleted 11y ago[deleted]
- skosuri 11y agoAccording to cell, he did disclose it and they chose not to use it because he didn't have a personal financial stake [1]. As a note, Doudna's review also had no conflict of interest despite her personal stake. 1. https://twitter.com/stephenfloor/status/688466159021064192 https://twitter.com/stephenfloor/status/688466159021064192
- Gatsky 11y agoDoudna's article is a typical scientific review written by someone intimately involved in the research. She doesn't try to teach 'important lessons', or outline the history of CRISPR, nor does she draw on unquoted 'personal interviews and other materials'. Everything is referenced, you can go and read each paper she cites. You can also compare her review to countless others written by her colleagues and patent opponents. Scientific reviews are invariably invited by the journal, with authors chosen based on their research interests and scientific output. Lander's article is a completely different beast. I highly doubt Cell cold called Eric Lander and asked him to write a campfire history of CRISPR. It is clear the Cell has a liberal COI policy in any case. I can't find COI mentioned anywhere, even to say that there aren't any.
- skosuri 11y agoBut reviews at Cell are academic papers; they are peer reviewed. Doudna has direct financial conflicts, it should have been disclosed. The viewpoints are usually solicited and not peer reviewed (at least ones I've been involved with), and are often meant to have an individual's biased and perhaps provocative viewpoint. Regardless, I think most of the COI argument is a little silly. None of these folks are particularly motivated by the money.
- reasonattlm 11y agoSo it is today technically possible to run a gene therapy in adult humans via CRISPR and some recent innovations in vectors with a good expectation that tissue coverage is going to be what you want it to be - i.e. enough cells take up changes for it to work. (See for example http://today.duke.edu/2015/12/crisprmousedmd http://today.duke.edu/2015/12/crisprmousedmd for the good tissue coverage angle). This is going to be next year's medical tourism, analogous to the progression of stem cell therapies from the turn of the century. There are a few really obvious candidates, such as myostatin and follistatin to greatly increase muscle growth - and at least one person who has had that done already, c.f. BioViva. To do this all you need are the connections. Buy into a biotech startup company, make the arrangement with a lab in Mexico or Thailand and off you go. If you knew the right people, you could be on a plane tomorrow and the beneficiary of elective gene therapy the day afterwards. It can't be overstated how easy CRISPR makes this. It is easier even than induced pluripotency, and that spread like wildfire through the labs when it emerged. The more interesting thing to me is that there are probably a hundred less obvious, poorly studied, poorly followed up, but very interesting genetic alterations that could be done, and probably will be done largely outside the institutions of medical research. This is what happens when cost falls. Any single gene is fair game now. Want great resistance to ischemia/reperfusion injuries? Knock out PHD1 [1]. Want your aged liver to function as well as it did when you were young? Add more lysosomal receptors. [2] Want to have permanent operation of the benefits of fasting and exercise in the form of upregulated autophagy? Increase AMPK levels [3]. And so on and so forth through scores of genes. Maybe many of them will work as the studies suggest, maybe not. [1]: http://www.vib.be/en/news/Pages/-VIB-researchers-discover-possible-strategy-against-stroke.aspx http://www.vib.be/en/news/Pages/-VIB-researchers-discover-po... [2]: http://www.nytimes.com/2009/10/06/science/06cell.html http://www.nytimes.com/2009/10/06/science/06cell.html [3]: http://www.salk.edu/news-release/how-the-cells-power-station-survives-attacks/ http://www.salk.edu/news-release/how-the-cells-power-station...
- ericb 11y agoIt seems like one thing that CRISPR brings to the table is find and replace, or find and delete. As a layman, this would seem ideal for treating any sort of cancer... Just find the distinct sequences and delete? What bad news do I not (yet) know that makes it much tougher than I'm hoping?
- Q6T46nT668w6i3m 11y agoRe: bad news --- a "find and replace" feature where unmatched tokens were replaced with unusual values.
- a_bonobo 11y agoSadly, cancer goes way beyond some broken DNA, in cancer cells you have polyploidy = several chromosome copies, these copies break up in weird ways so that some chromosomes are joined to others and other random mixing, you can't fix that using CRISPR You could, however, identify regions of DNA which make your cells more susceptible to the transformation, but CRISPR is still more unstable than the OP makes you think - in the highly debated human CRISPR experiment (using an older protocol) the scientists started with 86 embryos, of which 71 survived, of which only "a fraction" was successfully transformed, and in another fraction of that the proper target was hit but only in mosaics (with non-transformed cells remaining), in the remaining successful transformed cells the new DNA was inserted in the wrong position (potentially creating a new disease). See Carl Zimmer's take here: http://phenomena.nationalgeographic.com/2015/04/22/editing-human-embryos-so-this-happened/ http://phenomena.nationalgeographic.com/2015/04/22/editing-h... There's a lot of hype which IMHO damages the technology, it's much more finicky than it's usually presented
- jamescostian 11y agoAnother thing to consider is that one could use CRISPR to make lives worse. What if someone gave Michelle Obama a very high chance of breast or ovarian cancer by giving her BRCA1 or BRCA2[0]? What if a dictator's competition got sickle-cell anemia all of a sudden, or lost their sickle-cell anemia before their trip to a malaria zone (which is also bad[1])? [0] http://www.ncbi.nlm.nih.gov/pubmed/12677558 http://www.ncbi.nlm.nih.gov/pubmed/12677558 [1] http://www.cdc.gov/malaria/about/biology/sickle_cell.html http://www.cdc.gov/malaria/about/biology/sickle_cell.html
- jallmann 11y agoReally great article, especially for someone like me who only has a layman's understanding of the biology involved. Thinking out loud: In computer science terms, the method scientists use to discover and characterize genes (CRISPR, etc) seems akin to studying the assembly of a program, occasionally splicing chunks of assembly into other programs, and observing changes in the output after running. This sounds like a huge slog, and it is amazing that the method works. One interesting thing from the article was that, even after determining the function of CRISPR, scientists still had difficulty in understanding the mechanical/chemical means of its behavior: the gene is a black box, and its expression can only be deduced when observing its effects after running. Have there been attempts to characterize genes on a more basic level, eg by modelling how a given nucleotide sequence encodes a protein, and deducing its function from there? Is our understanding of protein folding still inadequate? Or would reconstructing a protein's physical structure still not give us enough insight into its intended function?
- reasonattlm 11y agoEvolution produces promiscuous reuse of component parts, and everything is linked to everything else: a cell is a bag of interacting feedback loops in solution. At a detail level, researchers still only have a sketch of the high points of cellular biochemistry. Any particular protein may have numerous roles, and scientists continue to uncover new important roles for even very well known proteins, those studied heavily for decades in some cases. Modeling is prevalent and helps. Deducing function with any accuracy requires much better and more comprehensive models of cellular biochemistry, however. Those models lie decades of work from here, meaning that altering genes and watching the outcome in mammalian cells and individuals will be the primary mode of exploration and validation for a while yet.
- sjg007 11y agoYep. It's basically debugging assembly code and also designing black and white box tests to figure out how the code works.
- deleted 11y ago[deleted]
- 11y ago
- Gatsky 11y agoFirst of all, why is a Lander writing this? What qualifies him to reconstruct the history of CRISPR? He doesn't do CRISPR research. Historical reviews are always written by the people that actually did the research because A) who else really knows what happened and B) we are interested in their perspective. So Lander's qualification is what exactly? That he's an important person who knows what DNA is? The article itself also absolutely stinks. First an ad hoc justification why this article is important consisting of nothing more than platitudes about science, then evocative descriptions of the weather in Santa Pola, progressively more brief descriptions of other sicentists' work followed by a long section at the end which could be a slightly edited version of the closing remarks from the Broad Institute's patent attorney in their dispute against the other CRISPR developers. This in particular, stinks: "The history also illustrates the growing role in biology of “hypothesis-free” discovery based on big data. The discovery of the CRISPR loci, their biological function, and the tracrRNA all emerged not from wet-bench experiments but from open-ended bioinformatic exploration of large-scale, often public, genomic datasets. “Hypothesis-driven” science of course remains essential, but the 21st century will see an increasing partnership between these two approaches." What 'growing role'? Biology has always been largely hypothesis-free. Which hypothesis was being tested when DNA was discovered? They were trying to fit a model to the data, not testing out their ideas about how DNA should look. Penicillin was discovered by accident, where was the hypothesis there? And the importance of bioinformatic exploration? How does this: "Using his word processor, Mojica painstakingly extracted each spacer and inserted it into the BLAST program to search for similarity with any other known DNA sequence" support the importance of bioinformatics? Manually pasting 4500 sequences into BLAST? Surely this is an example of progress DESPITE any substantial bioinformatics. I can't see why this was written except to further the agenda of the author and his institute, and to color history to support their legal claims. I can't see how this was published except through nepotism, eminence based science and the kind of shameful arrogance and entitlement that only academics have the luxury to cultivate. Maybe Lander thought he was setting the record straight, but that isn't his privilege.
- noname123 11y ago>Biology has always been largely hypothesis-free. I think Dr.Lander is talking about having open infrastructures and databases cataloging human genome variations; that allow everyone explore the datasets to find new patterns. You are right searching through BLAST is easy. However, maintaining and updating entries into the NCBI BLAST databases is not. Genomes are sequenced, assembled and submitted to NCBI every day. Cataloguing the variations in different strains of the different species, and identifying real novel evolutionary variations compared to just noises to existing reference genomes is not an easy task (1000 Genomes, dbSNP, malaria genome network, etc.) It is analogous to saying, Googling is easy but building and maintaining a search engine is not. I get what you are saying that some important discoveries are made by accidents, but the open data and intuitive platforms need to be there for the inspirational late night "Showerthought" googling-that-leads to-insight to happen in the first place.
- perugolate 11y agoThis is as partisan as inviting emperor palpatine to write a historical perspective to fill in the back story of the fall of the republic and the rise of the empire.
- Gatsky 11y agoAnyone that thinks this is a great article should read below, where the 'heroes' themselves say there are factual errors that were either not checked or not corrected. Lander really dropped the ball with this one. http://www.the-scientist.com/?articles.view/articleNo/45119/title/-Heroes-of-CRISPR--Disputed/ http://www.the-scientist.com/?articles.view/articleNo/45119/...